REPORT STATISTICS

Code:
MCP-3417

Pages:
139

Tables:
21

Companies:
41

PEPTIC ULCER TESTING: A RESEARCH BRIEF

The global market for Peptic Ulcer Testing is projected to reach US$525 million by 2022, driven by the growing disease prevalence rates in developing and developed countries alike both as a result of H. pylori infections and lifestyle and food habits such as excess consumption of fatty foods, untimely meal patterns, chronic acidity and food poisoning. The scenario creates the need for faster and accurate diagnosis of peptic ulcer. Asia-Pacific represents the largest market worldwide supported by the high incidence of H. pylori infections in developing Asian countries largely as a result of poor sanitary conditions and unsafe drinking water, which exposes a significant proportion of the population to the infection. Other factors driving growth in the region include growing healthcare spending as a result of rising disposable income, improving access to affordable healthcare as a result of government efforts to provide equitable healthcare services, and growing awareness over the importance of timely diagnosis and treatment of stomach ulcers. Unlike in Asia-Pacific, prevalence of H. pylori infection remains low and continues to decline at a steady rate in most developed countries.

Summary of Findings

Development of New Testing Techniques to Fuel Growth in the Market for Rapid Microbiological Tests

High Risk of Ulcer Morphing into Stomach Cancer Throws the Focus On Early Diagnosis and Timely Treatment of Peptic Ulcer

High Risk of Helicobacter Pylori Infections in the Elderly Brings Out Aging Population as a Key Demographic Growth Driver